Benzinga | Nov 5, 2020 04:20PM EST

Guardant Health Q3 EPS $(0.78) Misses $(0.39) Estimate, Sales $74.60M Beat $65.84M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.39) by 100 percent. This is a 457.14 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $74.60 million which beat the analyst consensus estimate of $65.84 million by 13.30 percent. This is a 22.60 percent increase over sales of $60.85 million the same period last year.